Cannabinoids, Like Those in Marijuana, May Protect Alzheimer’s Patients from Plaque Buildup

Cannabinoids, Like Those in Marijuana, May Protect Alzheimer’s Patients from Plaque Buildup
Alzheimer's disease has been described in medical literature for more than a century, but still has no effective treatments. Now, scientists at the Salk Institute in La Jolla, California, report finding evidence that tetrahydrocannabinol (THC), one of several physiologically active chemical compounds in marijuana, can promote cellular removal of amyloid beta, a toxic protein associated with Alzheimer's disease. While these exploratory studies were conducted with neurons grown in a laboratory, the researchers suggest they may offer insights into the role inflammation plays in Alzheimer's disease, and even point the way to developing therapeutic agents to treat this complex disorder. In a paper published in the journal
Subscribe or to access all post and page content.